Screener
Apogee Therapeutics, Inc. APGE Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Total operating expenses | 82,772 | 63,096 |
| Loss from operations | (82,772) | (63,096) |
| Other income, net: | ||
| Interest income, net | 8,740 | 7,840 |
| Total other income, net | 8,740 | 7,840 |
| Net loss before taxes | (74,032) | (55,256) |
| Provision for income taxes | (79) | (83) |
| Net loss after taxes | $(74,111) | $(55,339) |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s interest income?
- Apogee Therapeutics, Inc. (APGE) reported interest income of $8.74M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s interest income changed year-over-year?
- Apogee Therapeutics, Inc.'s interest income increased by 11.5% year-over-year, from $7.84M to $8.74M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s interest income?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s interest income has grown at a 82.5% compound annual growth rate (CAGR), from $9.02M to $30.03M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Apogee Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude